Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-04-23

Clinical Trial Update: A Study Comparing Recurrent Use of MSIR, Percocet, and Vicodin at Discharge From the ED [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing recurrent use of MSIR, Percocet, and Vicodin at ED discharge was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MSIR (morphine sulfate)
  • Percocet (oxycodone/acetaminophen)
  • Vicodin (hydrocodone/acetaminophen)

Snippet

Sponsor: Antonios Likourezos | Conditions: Pain | Phase 4 | Status: WITHDRAWN